Probiotic Formulations: Application and Status as Pharmaceuticals-A Review

Probiotics and Antimicrobial Proteins

Volumn 5, Issue 2, 2013, Pages 81-91

  Sreeja, V ^a   Prajapati, Jashbhai B ^a  

^a ANAND AGRICULTURAL UNIVERSITY   (India)

Author keywords

Pharmaceuticals; Probiotic preparations; Probiotic therapy; Probiotics; Regulations

Indexed keywords

ABC DOPHILUS POWDER FOR INFANTS AND CHILDREN; ACIDOPHILUS PEARL; ALACFORTE; ALIGN; BABYLAC; BACILLUS PROBIOTIC AGENT; BIFIDOBIOTICS; BIFIFORM; BIOHEADS PROBIOTIC ACIDOPHILUS; BLIS K12; CULTURELLE; DAROLAC; EXCIPIENT; FLORA FIVE PROBIOTIC PEARLS; FLORA Q; FLORASTOR; GOOD START SUPREME; HOWARU BALANCE; HOWARU PROTECT; HOWARU RESTORE; IDOFORM; IDOFORM A BIOTIC; IDOFORM CLASSIC PLUS; IDOFORM TRAVEL; L REUTERI PROTECTIS; LAC; LACBON; LACTOGENES DT; LACTOSPORE; LAFLOR; LINEX FORTE; NATURES BIOTICS; PLACEBO; PRIMADOPHILUS PRODIFIA PEARL; PRIMAL DEFENSE KIDS; PRO BIOTEC; PROBIO TEC; PROBIOKID; PROBIOTIC AGENT; PROBIOTIC PEARL; PROBIOTICA; PROTECFLOR; SANVITA; SMARTER PROBIOTICS; SPORLAC; SYNBIOTIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VSL3;

ARTICLE; BLOATING; COLIC; COMMON COLD; DIARRHEA; DIET SUPPLEMENTATION; DRUG FORMULATION; DRUG INDUSTRY; FERMENTED PRODUCT; FOOD INTAKE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TRACT; HELICOBACTER INFECTION; HUMAN; IMMUNITY; INFECTION; INFECTION CONTROL; INFLUENZA; IRRITABLE COLON; LACTOBACILLUS; LACTOBACILLUS BIFIDUS; LACTOBACILLUS SPOROGENES; PRIORITY JOURNAL; PROPHYLAXIS; PROTECTION; RISK REDUCTION; TRAVELLER DIARRHEA; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; VAGINA DISEASE;

EID: 84877631179     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-013-9126-2     Document Type: Article

References (94)

1. Elmer GW (2001) Probiotics: 'living drugs'. Am J Health-Syst Pharm 58(12): 1101-1109.
2. Kaur IP, Chopra K, Saini A (2002) Probiotics: potential pharmaceutical applications. Eur J Pharm Sci 15: 1-9.
3. Sanders ME (2003) Probiotics: considerations for human health. Nutr Rev 61(3): 91-99.
4. Lemberg DA, Ooi CY, Day AS (2007) Probiotics in paediatric gastrointestinal diseases- Review. J Paediatr Child Health 43: 331-336.
5. Fuller R (1991) Probiotics in human medicine. Gut 32: 439-442.
6. Sleator RD (2010) Probiotic therapy-recruiting old friends to fight new foes. Gut Pathog 2: 51-54.
7. Raja BR, Arunachalam KD (2011) Market potential for probiotic nutritional supplements in India. AJBM 5(14): 5418-5423.
8. Dubey AP, Rajeshwari K, Chakravarty A, Famularo G (2008) Use of VSL[#]3 in the treatment of rotavirus diarrhea in children: preliminary results. J Clin Gastroenterol 42(Suppl 3 Pt 1): S126-S129.
9. McFarland LV (2007) Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 5: 97-105.
10. Saavedra JM (2001) Clinical applications of probiotic agents. Am J Clin Nutr 73(suppl): 1147S-1151S.
11. Salminen S (2001) Human studies on probiotics: aspects of scientific documentation-review. Scand J Nutr 45: 8-12.
12. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG (2012) Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307(18): 1959-1969.
13. Culligan EP, Hill C, Sleator RD (2009) Probiotics and gastrointestinal disease: successes, problems and future prospects-review. Gut Pathog 1(19): 1-12.
14. Gill HS, Guarner F (2004) Probiotics and human health: a clinical perspective. Postgrad Med J 80: 516-526.
15. Barrons R, Tassone D (2008) Use of lactobacillus probiotics for bacterial genitourinary infections in women: a Review. Clin Ther 30: 453-468.
16. Parvez S, Malik KA, Ah Kang S, Kim HY (2006) Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 100: 1171-1185.
17. Pantoflickova DL, Theulaz IC, Blum AL (2007) Helicobacter pylori and Probiotics. J Nutr 812S-818S.
18. Bhattacharyya BK (2009) Emergence of probiotics in therapeutic applications. Int J Pharm Sci Nanotechol 2: 383-389.
19. Marteau P, Shanahan F (2003) Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Pract Res Clin Gastroenterol 17: 725-740.
20. FAO/WHO (2002) Guidelines for the evaluation of probiotics in food. http://www. who. int/foodsafety/fs_management/en/probiotic_ guidelines.
21. Osvath R (2000) FDA food advisory committee to discuss criteria for safety of probiotics. Food Chem News 42: 12.
22. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30: 1604-1610.
23. Schiffrin EJ, Brassart D, Servin AL, Rochat F, Donnet-Hughes A (1997) Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 66(2): 515S-520S.
24. Chouraqui JP, van Egroo LD, Fichot MC (2004) Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 38: 288-292.
25. Marteau P, de Vrese M, Cellier C, Schrezenmeir J (2001) Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 73: 430S-436S.
26. Shioya M, Nakaoka K, Igarashi R, Iizuka N, Abe T, Benno Y (2000) Effect of fermented milk containing Bifidobacterium lactis FK 120 on the fecal flora and fecal properties in healthy female volunteers. Food Health and Nutrition Research. J Nutr Fd 3: 7-18.
27. de Vrese M, Rautenberg P, Laue C, Koopmans M, Herremans T, Schrezenmeir J (2005) Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr 44: 406-413.
28. Gaon D, Garcia H, Winter L, Rodriguez N, Quintasi R, Gonzalez SN, Oliver G (2003) Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina 63: 293-298.
29. Saavedra JM, Abi-Hanna A, Moore N, Yolken RH (2004) Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 79: 261-267.
30. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH (1994) Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 344: 1046-1049.
31. Sullivan Å, Bennet R, Viitanen M, Palmgren AC, Nord CE (2002) Influence of Lactobacillus F19 on intestinal microflora in children and elderly persons and impact on Helicobacter pylori infections. Microbial Ecol Health Dis Suppl 3: 17-21.
32. Cox AJ, Pyne DB, Saunders PU, Fricker PA (2010) Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med 44: 222-226.
33. French PW, Penny R (2009) Use of probiotic bacteria as an adjuvant for an influenza vaccine. Int J Probiotics Prebiotics 4(3): 175-180.
34. Ringel-Kulka T, Palsson OS, Maier D et al (2011) Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol 45(6): 518-525.
35. Hojsak I, Snovak N, Abdovic S, Szajewska H, Misak Z, Kolacek S (2010) Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr 29(3): 312-316.
36. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T (1991) A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88: 90-97.
37. Heyman M, Ménard S (2002) Probiotic microorganisms: how they affect intestinal Pathophysiology. CMLS 59: 001-15.
38. Shimauchi H, Mayanagi G, Nakaya S et al (2008) Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. J Clin Periodontol 35: 897-905.
39. Hoffman FA (2008) Development of probiotics as biologic drugs. Clin Infect Dis 46(Suppl 2): S125-S127.
40. Ross J (2006) Regulatory considerations. In american society for microbiology colloquium report probiotic microbes: the scientific basis. American Academy of Microbiology, Washington, p 8.
41. Vaillancourt J (2006) Regulating Pre-and Pro-biotics: A US FDA Perspective. In Institute of medicine report of the forum on microbial threats workshop summary. Ending the war metaphor: the future agenda for unraveling the host-microbe relationship. National Academies Press, Washington, pp 229-237.
42. Gibson GR, Brummer RJ, Isolauri E, Lochs H, Morelli L, Ockhuizen T, Rowland IR, Schrezenmeir J, Stanton C, Verbeke K (2011) The design of probiotic studies to substantiate health claims. Gut Microbes 2(5): 299-305.
43. Mercenier A, Pavan S, Pot B (2002) Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 8: 99-110.
44. Saxelin M (2008) Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective. Clin Infect Dis 46: S76-S79.
45. ICMR-DBT (2011) Guidelines for evaluation of probiotics in food. Director General, Indian Council of Medical Research, New Delhi-110 029.
46. Food Safety and Standards Act of India (2006) Ministry of health and family welfare. New Delhi, Government of India.
47. Czinn SJ, Blanchard SS (2009) Probiotics in foods and supplements. In: Michail S, Sherman PM (eds) Nutrition and health: probiotics in Pediatric Medicine, © Humana Press. NJ, Totowa, pp 299-306.
48. Bora PS, Puri V, Bansal AK (2009) Physicochemical properties and excipient compatibility studies of probiotic Bacillus coagulans spores. Sci Pharm 77: 625-637.
49. Yang L, Chu JS, Fix JA (2002) Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm 235: 1-15.
50. Prakash S, Urbanska AM (2008) Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells- Review. Biolog Targets Ther 2(3): 355-378.
51. Mombelli B, Gismondo MR (2000) The use of probiotics in medical practice. Int J Antimicrobial Agents 16: 531-536.
52. Forum Pharmacopeial (2007) Proposed New USP General Information Chapter. Excipient Performance 33(6): 1311-1323.
53. http://www. daniscosupplements. com.
54. Tursi A, Brandimarte G, Papa A et al (2010) Treatment of relapsing mild-to-moderate Ulcerative Colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a Double-Blind, Randomized, Placebo-Controlled Study. Am J Gastroenterol 105: 2218-2227.
55. Kim HJ, Camilleri M, McKinzie S et al (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17: 895-904.
56. Kim HJ, Vazquez Roque MI, Camilleri M et al (2005) A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 17: 687-696.
57. Andresen V, Baumgart DC (2006) Role of probiotics in the treatment of irritable bowel syndrome: potential mechanisms and current clinical evidence. Int J Probiotics Prebiotics 1: 11-18.
58. ® in reducing the risk of infections in infancy. British. J Nutr 105(3): 409-416.
59. Rizzardini G, Eskesen D, Calder PC, Capetti A, Jespersen L, Clerici M (2011) Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12w and Lactobacillus paracasei ssp. paracasei, L. casei 431w in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. British J Nutr 1-9.
60. ®) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athletes. Nutr J 10: 1-11.
61. Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajezyk W (2001) Efficacy of Lactobacillus sp strain GG in prevention of nosocominal diarrhea in infants. J Pediatr Gastroenterol Nutr 138: 361-365.
62. ®) for prevention of antibiotic-associated diarrhea in Indian patients. J Clin Pharmacol 51: 1327.
63. Sheu BS, Wu JJ, Lo CY (2002) Impact of supplement with Lactobacillus-and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 16: 1669-1675.
64. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ (1999) Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatrics 135(5): 564-568.
65. Reid G, Charbonneau D, Erb J et al (2003) Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 35(2): 131-134.
66. Petricevic L, Unger FM, Viernstein H, Kiss H (2008) Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Europe J Obstetr Gynecol Reprod Biol 141(1): 54-57.
67. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW, Reid G (2006) Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect 8: 1450-1454.
68. Martinez RC, Franceschini SA, Patta MC et al (2009) Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebocontrolled trial. Canadian J Microbiol 55(2): 133-138.
69. Martinez RC, Franceschini SA, Patta MC et al (2009) Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol 48(3): 269-274.
70. ® and Bifidobacterium lactis Bi-07 improve symptoms of bloating patients with functional bowel disorders (FBD). Gastroentero 134(4 Suppl. 1): A549.
71. www. Howaru. com.
72. http://www. naturalproductsinsider. com/news/2011/05/danisco-probiotics-reduce- bloating. aspx.
73. Tubelius P, Stan V, Zachrisson A (2005) Increasing work-place healthiness with the probiotic Lactobacillus reuteri: a randomised, double blind placebo-controlled study. Environment Health 4: 25.
74. Weizman Z, Asli G, Alsheikh A (2005) Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115: 5-9.
75. Lionetti E, Miniello VL, Castellaneta SP et al (2006) Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomised placebo controlled trial. Aliment Pharmacol Ther 24: 1461-1468.
76. Savino F, Pelle E, Palumeri E, Oggero R, Miniero R (2007) Lactobacillus reuteri (American Type Culture Collection strain ATCC 55730) versus Simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 119: 124-130.
77. Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR (2006) A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol 100: 754-764.
78. Pham-Thi N, Durand H, Kerihuel JC, Bohbot S (2009) Evaluation of the effects of a synbiotic supplement on the incidence of infectious episodes in children: Randomized, controlled, multicentre study. Oral communication at the 5th Probiotics, Prebiotics AND New Foods Meeting, Rome.
79. Doron SI, Hibberd PL, Gorbach SL (2008) Probiotics for prevention of antibiotic-associated diarrhea. J Clin Gastroenterol 42(Supplement 2): S58-S63.
80. Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ (2011) A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. J Clin Gastroenterol 45: 679-683.
81. Berman SH, Eichelsdoerfera P, Yima D, Elmerb GW, Wenner CA (2006) Daily ingestion of a nutritional probiotic supplement enhances innate immune function in healthy adults. Nutr Res 26: 454-459.
82. http://www. vitacost. com/NSI-Immunobiotix.
83. De Vecchi E, Drago L (2006) Lactobacillus sporogenes or Bacillus coagulans: misidentification or mislabelling? Int J Probiotics Prebiotics 1: 3-10.
84. http://www. purecaps. com.
85. http://www. lactospore. com/benifit. htm.
86. http://www. allvita. net/probiotics. htm.
87. http://www. getwellnatural. com/probiotic-pearls. aspx.
88. http://www. lek. si/en/media-room/press-releases/571.
89. http://www. ferrosan. com.
90. http://www. ncbi. nlm. nih. gov/pubmed/16613091.
91. http://www. expresspharmaonline. com/20080430/research01. shtml.
92. Tannok GW (2003) Probiotics: time for a Dose of Realism. Curr Issues Intest Microbiol 4: 33-42.
93. Boyle RJ, Robins-Browne RM, Tang MLK (2006) Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83: 1256-1264.
94. Sheldon T (2008) Dutch trial of probiotics in acute pancreatitis is to be investigated after deaths. BMJ 336(7639): 296-297.